PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp insiders are currently net sellers of PRCT stock, showing bearish sentiment over the past 90 days. Total sales of $85.0M outpace purchases of $47.4M, creating a net outflow of $37.5M. However, 64% of these sales are pre-scheduled 10b5-1 plan transactions.

PROCEPT BioRobotics Corp has 19 active insiders who have filed SEC Form 4 transactions in the past 90 days. Global Opportunities Parent Gp Llc Viking (Executive) leads with 2 transactions totaling $37.3M. Antal Rohit Desai (Executive) follows with 40 transactions worth $28.2M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. PROCEPT BioRobotics Corp's current score of 36/100 indicates bearish insider sentiment. Scores below 40 indicate selling pressure exceeds buying. Insider selling often reflects diversification needs, tax optimization, or estate planning.

The most recent insider transaction occurred on Mar 17, 2026, when Waters Kevin (EVP, CFO) disposed of 706 shares at $28.15 per share for $19.9K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, PRCT insider trading sentiment is currently bearish with an Alignment Score of 36/100. The negative net flow of $37.5M shows more selling than buying. However, 64% of recent transactions are 10b5-1 scheduled trades.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like PROCEPT BioRobotics Corp. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At PRCT, we track all Form 4 filings—currently showing 254 transactions from 19 insiders over 90 days.

A 10b5-1 plan allows PROCEPT BioRobotics Corp executives to pre-schedule stock sales when they don't possess material non-public information. At PRCT, approximately 64% of recent transactions are 10b5-1 trades. This high percentage suggests much of the selling is routine and pre-planned.

You can monitor PROCEPT BioRobotics Corp (PRCT) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 19 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. PROCEPT BioRobotics Corp's current score of 36/100 indicates moderately bearish sentiment with selling outpacing buying. This is calculated from $47.4M in purchases versus $85.0M in sales over 90 days, resulting in a net flow of -$37.5M.

SEC Form 4 filings are mandatory reports that PROCEPT BioRobotics Corp insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At PRCT, the most common type is "S" with 28 occurrences. The most recent Form 4 was filed on Mar 17, 2026 by Waters Kevin.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At PROCEPT BioRobotics Corp, approximately 64% of recent transactions are executed under 10b5-1 plans, while 36% appear to be discretionary trades. This high percentage suggests selling activity may be routine diversification.